A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/48 (2006.01) A61K 9/00 (2006.01)
Patent
CA 2708762
The present invention provides pharmaceutical formulations comprising insulinotropic peptide conjugates, particularly a conjugate of albumin to exendin-4, or a derivative therof, and methods of administration thereof. The present invention also provides methods for treating diabetes and insulinotropic peptides related diseases or conditions by administering the pharmaceutical formulations described herein.
La présente invention concerne des formulations pharmaceutiques qui comprennent des conjugués de peptides insulinotropes, en particulier un conjugué d'albumine à l'exendine-4, ou un dérivé de celui-ci, et les procédés d'administration de celles-ci. La présente invention concerne également des procédés de traitement du diabète et de maladies ou d'affections associées á des peptides insulinotropes par l'administration des formulations pharmaceutiques décrites ici.
Carrier Marieve
Chang Byeong Seon
Estradier Jean-Philippe
Quraishi Omar
Ulich Thomas R.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Conjuchem Biotechnologies Inc.
LandOfFree
Formulation of insulinotropic peptide conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Formulation of insulinotropic peptide conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulation of insulinotropic peptide conjugates will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1740254